Howard Lapsley

Blog Entry Image

11 Disruption Market Scenarios from the Outside In

From Walmart to Amazon to 23andMe, these 11 market scenarios paint a picture of what disruption looks like, both in and out of healthcare.

Howard Lapsley portrait

Howard Lapsley

Partner, Health & Life Sciences, Oliver Wyman
Charlie Hoban portrait

Charlie Hoban

Partner, Health & Life Sciences, Oliver Wyman
Sukanya Soderland portrait

Sukanya Soderland

Former Partner, Oliver Wyman; Chief Strategy Officer, Blue Cross Blue Shield of Massachusetts
Chris Schrader portrait

Chris Schrader

Principal, Health & Life Sciences, Oliver Wyman
Blog Entry Image

Opportunities in Voluntary Benefits

In the face of today’s market turmoil and revenue insecurity, ancillary products offer a stable, growing profit pool for health plans.

Chris Bernene portrait

Chris Bernene

Partner, Health & Life Sciences, Oliver Wyman
Howard Lapsley portrait

Howard Lapsley

Partner, Health & Life Sciences, Oliver Wyman

A Tale of Two Retailers and What it Means for Healthcare

Earlier this week, on the same day, Gap announced it was closing 175 or 25% of its retail stores, while CVS Health proclaimed it was purchasing Target’s pharmacy and clinic business for $1.9 billion as part of an aggressive expansion push.

Howard Lapsley portrait

Howard Lapsley

Partner, Health & Life Sciences, Oliver Wyman
Blog Entry Image

Insights: Health Plans' Evolving View of Retail Health

Traditionally, visits to retail clinics were almost an entirely out-of-pocket expense. Now, as Forbes reports, retailers like CVS, Walgreens, and Wal-Mart are finding that the majority of their clinics’ visits are covered by insurance. Oliver Wyman’s Howard Lapsley puts this milestone into perspective.

Howard Lapsley portrait

Howard Lapsley

Partner, Health & Life Sciences, Oliver Wyman